Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Roivant Sciences Ltd. (ROIV) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Roivant Sciences Ltd. (ROIV) on November 12, 2026 is 40.22 $, −3.89 % on the day. Over 52 weeks the stock traded between 19.96 $ and 42.50 $; the price now sits 90 % of the way up that range. Over the past year the price changed by +100.24 %. Market capitalization is 30.34 billion $, rank 13 among 384 stocks of the same industry with a known capitalization.
Roivant Sciences Ltd. trades on Nasdaq under the ticker ROIV. The company belongs to the Health care sector. The trading history on this page starts on 8 December 2020.
Over the past 52 weeks ROIV has traded between 19.96 $ and 42.50 $. As of 12 November 2026 the price stood 97.12% of the way from the 52-week low to the high.
Over one year ROIV shares rose 100.24%; over six months they rose 43.22%. Volatility over 90 days is 47.78%. Dividends are not included: this is price change only, as of 12 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 4,028, above the sector median of 3.9. Price to book is 7.2, above the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
ROIV has a return on equity of −6.29%, above the sector median of −40.58%. Return on assets is −5.02%, above the sector median of −30.08%.